KCLU 88.3FM - 102.3FM - 1340AM

Listen Now

BBC World Service
12:00am - 5:00am

Amgen Settles Charge It Marketed One Of Its Drug For Unapproved Uses

Posted on Wednesday, December 19, 2012 12:41am

A biotech giant based in Ventura County agreed to pay more than $760 million dollars to settle charge that it marketed one of its drugs for unapproved uses.

The U.S. Attorney’s Office in New York says Amgen pled guilty to illegally introducing a misbranded drug into interstate commerce, and will pay a total of $150 million dollars.

The issue was the marketing of the anemia drug Aranesp.

A law firm says the Thousand Oaks company will also pay more than $600 million dollars to settle civil litigation involved with the case.

However, that deal hasn’t been confirmed by prosecutors. A judge will decide today whether to accept the plea, and settlement in the case.

KCLU Local News

KCLU Featured Stories